ArticleCancer gene therapy2022

Regional infusion of a class C TLR9 agonist enhances liver tumor microenvironment reprogramming and MDSC reduction to improve responsiveness to systemic checkpoint inhibition.

Chandra C Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.